161 related articles for article (PubMed ID: 34995453)
1. Analgesic Opioid Ligand Discovery Based on Nonmorphinan Scaffolds Derived from Natural Sources.
Smith MT; Kong D; Kuo A; Imam MZ; Williams CM
J Med Chem; 2022 Feb; 65(3):1612-1661. PubMed ID: 34995453
[TBL] [Abstract][Full Text] [Related]
2. Biased Opioid Ligands.
Faouzi A; Varga BR; Majumdar S
Molecules; 2020 Sep; 25(18):. PubMed ID: 32948048
[TBL] [Abstract][Full Text] [Related]
3. The opioid receptor triple agonist DPI-125 produces analgesia with less respiratory depression and reduced abuse liability.
Yi SP; Kong QH; Li YL; Pan CL; Yu J; Cui BQ; Wang YF; Wang GL; Zhou PL; Wang LL; Gong ZH; Su RB; Shen YH; Yu G; Chang KJ
Acta Pharmacol Sin; 2017 Jul; 38(7):977-989. PubMed ID: 28502978
[TBL] [Abstract][Full Text] [Related]
4. Bifunctional μ opioid and σ
Zhuang T; Xiong J; Hao S; Du W; Liu Z; Liu B; Zhang G; Chen Y
Eur J Med Chem; 2021 Nov; 223():113658. PubMed ID: 34175542
[TBL] [Abstract][Full Text] [Related]
5. Replacement of current opioid drugs focusing on MOR-related strategies.
Busserolles J; Lolignier S; Kerckhove N; Bertin C; Authier N; Eschalier A
Pharmacol Ther; 2020 Jun; 210():107519. PubMed ID: 32165137
[TBL] [Abstract][Full Text] [Related]
6. Dilemma of Addiction and Respiratory Depression in the Treatment of Pain: A Prototypical Endomorphin as a New Approach.
Webster L; Schmidt WK
Pain Med; 2020 May; 21(5):992-1004. PubMed ID: 31165885
[TBL] [Abstract][Full Text] [Related]
7. Intracerebroventricular administration of CYX-6, a potent μ-opioid receptor agonist, a δ- and κ-opioid receptor antagonist and a biased ligand at μ, δ & κ-opioid receptors, evokes antinociception with minimal constipation and respiratory depression in rats in contrast to morphine.
Imam MZ; Kuo A; Ghassabian S; Cai Y; Qin Y; Li T; Smith MT
Eur J Pharmacol; 2020 Mar; 871():172918. PubMed ID: 31958457
[TBL] [Abstract][Full Text] [Related]
8. Historical perspectives and recent advances in small molecule ligands of selective/biased/multi-targeted μ/δ/κ opioid receptor (2019-2022).
He Y; Su Q; Zhao L; Zhang L; Yu L; Shi J
Bioorg Chem; 2023 Dec; 141():106869. PubMed ID: 37797454
[TBL] [Abstract][Full Text] [Related]
9. [Development of opioid tolerance -- molecular mechanisms and clinical consequences].
Freye E; Latasch L
Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):14-26. PubMed ID: 12522725
[TBL] [Abstract][Full Text] [Related]
10. Opioid ligands with mixed mu/delta opioid receptor interactions: an emerging approach to novel analgesics.
Ananthan S
AAPS J; 2006 Mar; 8(1):E118-25. PubMed ID: 16584118
[TBL] [Abstract][Full Text] [Related]
11. Hot topics in opioid pharmacology: mixed and biased opioids.
Azzam AAH; McDonald J; Lambert DG
Br J Anaesth; 2019 Jun; 122(6):e136-e145. PubMed ID: 31010646
[TBL] [Abstract][Full Text] [Related]
12. The multifunctional peptide DN-9 produced peripherally acting antinociception in inflammatory and neuropathic pain via μ- and κ-opioid receptors.
Xu B; Zhang M; Shi X; Zhang R; Chen D; Chen Y; Wang Z; Qiu Y; Zhang T; Xu K; Zhang X; Liedtke W; Wang R; Fang Q
Br J Pharmacol; 2020 Jan; 177(1):93-109. PubMed ID: 31444977
[TBL] [Abstract][Full Text] [Related]
13. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
14. Peripheralization Strategies Applied to Morphinans and Implications for Improved Treatment of Pain.
Schmidhammer H; Al-Khrasani M; Fürst S; Spetea M
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375318
[TBL] [Abstract][Full Text] [Related]
15. Peptide-derived ligands for the discovery of safer opioid analgesics.
Eliasof A; Liu-Chen LY; Li Y
Drug Discov Today; 2024 May; 29(5):103950. PubMed ID: 38514040
[TBL] [Abstract][Full Text] [Related]
16. Ligand requirements for involvement of PKCε in synergistic analgesic interactions between spinal μ and δ opioid receptors.
Schuster DJ; Metcalf MD; Kitto KF; Messing RO; Fairbanks CA; Wilcox GL
Br J Pharmacol; 2015 Jan; 172(2):642-53. PubMed ID: 24827408
[TBL] [Abstract][Full Text] [Related]
17. Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain.
Podolsky AT; Sandweiss A; Hu J; Bilsky EJ; Cain JP; Kumirov VK; Lee YS; Hruby VJ; Vardanyan RS; Vanderah TW
Life Sci; 2013 Dec; 93(25-26):1010-6. PubMed ID: 24084045
[TBL] [Abstract][Full Text] [Related]
18. Novel GPCR paradigms at the μ-opioid receptor.
Thompson GL; Kelly E; Christopoulos A; Canals M
Br J Pharmacol; 2015 Jan; 172(2):287-96. PubMed ID: 24460711
[TBL] [Abstract][Full Text] [Related]
19. Epidural opioid analgesia in infant rats II: responses to carrageenan and capsaicin.
Marsh D; Dickenson A; Hatch D; Fitzgerald M
Pain; 1999 Jul; 82(1):33-38. PubMed ID: 10422657
[TBL] [Abstract][Full Text] [Related]
20. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]